Navigation Links
ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
Date:12/17/2009

encouraging for the prospects of ANA598 contributing to improved long-term treatment outcomes as measured by SVR."

In the ongoing Phase II study, patients are to receive ANA598 or placebo, added to SOC, for 12 weeks, after which they are to continue receiving SOC alone for 12 or 36 additional weeks. The results announced today are from a scheduled interim analysis following four weeks of dosing in the first of two planned dose cohorts. 44 patients in the first cohort (34 genotype 1a and 10 genotype 1b) received at least one dose of study medications, 29 receiving ANA598 and 15 receiving placebo. Two patients who withdrew consent during the first week of dosing for reasons unrelated to ANA598 are excluded from the analysis of antiviral response but included in the safety database. Reported antiviral response data is as of week 4. Reported safety data is as of an interim analysis date which was reached shortly after the last enrolled patient completed four weeks of dosing, and includes information through week 4 for all patients plus information subsequent to week 4 for those patients who had earlier enrollment dates.


    Preliminary Antiviral Response Assessment

                         total             genotype 1a        genotype 1b
                        patients            patients            patients
                    ANA598    Placebo   ANA598    Placebo   ANA598   Placebo
                     +SOC      +SOC      +SOC      +SOC      +SOC     +SOC
                    ---------------------------------------------------------
    RVR
    ---
    Percentage
     of Patients
     with
     Undetectable     56%        20%      50%        17%       71%       33%
     HCV RNA        (15/27)    (3/15)   (10/20)    (2/12)     (5/7)     (1/3)
     (<15 IU/ml)
     at Week 4

    VIRAL LOAD
     CHANGE
    ----------
    Mean Decline
     in HCV
     RNA (log10
     IU/ml) at
     Week 4            4.1       2.7       4.2       2.4     
'/>"/>
SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
6. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
7. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
8. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
11. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014  InnoPharma, Inc. today announced the ... generic equivalent of Zyprexa® injection), in Canada.  Olanzapine is ... behaviors in patients with schizophrenia or bipolar I mania. ... drug, InnoPharma has entered into an agreement with Sandoz ... will make, use, sell, market and distribute Olanzapine Injection ...
(Date:7/30/2014)... and PARIS , July 30, ... ) and Sanofi (EURONEXT: SAN and NYSE: ... ODYSSEY trials of alirocumab in people with hypercholesterolemia met ... from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 ... an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin ...
(Date:7/30/2014)... NEW YORK , July 30, 2014 ... products for oncology supportive care, announced that its novel ... featured in an article on OncLive.com titled, "Study Finds ... Neck Cancers."  Dr. Steve Sonis , a leading ... demand seen in the oncology community for evidence-based strategies ...
Breaking Medicine Technology:InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3
... /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings ("Golden Meditech," 0801.HK, ... Bon International") today announced that the companies have ... strategic cooperation in Taipei.  Golden Meditech Holdings Chairman, ... International, Mr. Chu Powei, respectively represented and co-chaired ...
... BRUNSWICK, N.J., and LEIDEN, Netherlands, Feb. 17, 2011 ... (NYSE Euronext, Nasdaq: CRXL ; Swiss Exchange: CRX) today ... to acquire Crucell N.V. (Crucell) has been satisfied.  The initial offering ... a.m. New York time) on 16 February 2011.   ...
Cached Medicine Technology:Golden Meditech to Form Strategic Alliance with Long Bon International 2Golden Meditech to Form Strategic Alliance with Long Bon International 3Minimum Acceptance Condition Satisfied 2Minimum Acceptance Condition Satisfied 3Minimum Acceptance Condition Satisfied 4Minimum Acceptance Condition Satisfied 5Minimum Acceptance Condition Satisfied 6
(Date:7/30/2014)... 2014 Calling all runners in the Richmond, ... it will host a monthly Runner’s Injury Clinic ... Brick Road the second Monday of each month through the ... 13, November 10 and December 8. , The clinics ... should wear running shoes and attire, will receive a complimentary ...
(Date:7/30/2014)... (PRWEB) July 31, 2014 WalkingSticksandCane.com ... Walking Canes. The ladies will love the new European fashions ... Sticks . These sticks and canes are from one from ... England. Each of the styles re unique and offer the ... , The Blackthorn Walking Sticks are some of the rarest ...
(Date:7/30/2014)... Daily Gossip indicates in its 60 Second Panic Solution ... is a feeling of intense stress and fear, which may ... symptoms that sufferers commonly deal with when panic attacks are ... anxiety. Naturally, panic attacks deeply affect lifestyle; this is why ... , The 60 Second Panic Solution review promises to be ...
(Date:7/30/2014)... Daily Gossip mentions that the "Panic Away" method ... to stop anxiety and eliminate all associated symptoms. It has ... than 150,000 people in getting their lives back. , The ... treatment system that will teach sufferers different techniques on how ... simple to access, as it is available in a complex ...
(Date:7/30/2014)... 30, 2014 Serial entrepreneur, Paul Mata, spent ... millions. However, like most people, in 2008 he suffered extreme ... a better way, Paul carefully studied the difference between people ... do not. Based on the knowledge he acquired, he was ... his life and health, but also grow his clients' personal ...
Breaking Medicine News(10 mins):Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 2Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 3Health News:European Walking Sticks from WalkingSticksandCane.com 2Health News:60 Second Panic Solution Review Reveals Unique Way to Stop Panic Attacks 2Health News:Panic Away Review Reveals How to Stop Anxiety 2Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 2Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 3
... , , , , , WALTHAM, ... of the world,s leading research and advisory firms focusing on pharmaceutical ... averaged 40 percent less than U.S. prices in 2008. Within Europe ... prices in Italy to 70 percent of U.S. prices in Germany. ...
... Bear Naked, the natural foods innovator, announced today that it is ... of granola bars that offer active consumers a unique, on-the-go snacking alternative ... and available in three enticing flavors--Chocolaty Cherry, Tropical and Fruit and Nut-- ... & Na tu ral ...
... glaucoma , TUESDAY, July 7 (HealthDay News) -- A ... cerebral infarcts could help explain the medical mystery of ... the progressive loss of vision caused by deterioration of ... to the brain. It is customarily attributed to abnormally ...
... July 7 /PRNewswire-FirstCall/ - SXC Health Solutions Corp. ("SXC" ... SXC), a leading provider of technology and pharmacy benefit ... has been awarded an 18-month contract, with an option ... Presbyterian Health Plan, a health maintenance organization (HMO) based ...
... 7 "It,s time for Plaintiffs, attorneys to do ... we are making that happen," says Stephen Ambrose, CIO ... is a startup healthcare IT company which utilizes Collaborative ... as a request for a patient,s health record. This ...
... ... fitness, to attract and retain good talent. However, Freightquote took this industry initiative one ... mental health, financial wellbeing, and education. , ... Lenexa, KS (PRWEB) July 7, 2009 -- Freightquote.com ...
Cached Medicine News:Health News:European Prices of 170 Best-Selling Drugs Averaged 40 Percent Less Than U.S. Prices in 2008 2Health News:Bear Naked Introduces All Natural Granola Bars 2Health News:Mini-Strokes May Cause Vision Loss 2Health News:Mini-Strokes May Cause Vision Loss 3Health News:SXC Health Solutions announces PBM contract with Presbyterian Health Plan 2Health News:SXC Health Solutions announces PBM contract with Presbyterian Health Plan 3Health News:SXC Health Solutions announces PBM contract with Presbyterian Health Plan 4Health News:New Software Makes Lawyers Accountable for Their Part in Our Healthcare Crisis 2Health News:Freightquote.com Encourages Healthy Lifestyle, FreightFit Changes Lives 2Health News:Freightquote.com Encourages Healthy Lifestyle, FreightFit Changes Lives 3
A new flexible endoscope with an ultra dense optic fiber system. Its two working and irrigation channels and steering mechanism makes it ideal for a multipurpose use in neurosurgical endoscopy i.e. V...
... Performance Instrument System. It is the only ... electric power with the unparalleled high performance ... The advanced design of this instrument system ... cooling system, advanced control circuitry, and the ...
The XK-PRO 100 High Speed Drill System is a compact, lightweight design that offers new technological and performance standards for a combination of surgical procedures....
... The Legend Platinum is a compact ... 77,000 rpm at 120 psi/8 bar, ... of comparable size with noticeable noise ... design combines with an enhanced ergonomic ...
Medicine Products: